• Episode 9: What does new FDA leadership mean for the dietary supplement industry?

  • 2022/03/24
  • 再生時間: 20 分
  • ポッドキャスト

Episode 9: What does new FDA leadership mean for the dietary supplement industry?

  • サマリー

  • In this episode, the Nutritional Outlook editors interview Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP’s FDA and Healthcare practices. Previously, Durkin worked as the acting director and deputy director of the Office of Dietary Supplement Programs, in the FDA’s Center for Food Safety and Applied Nutrition. Given Durkin’s experience at FDA, he is well-qualified to provide some insights into how the leadership of FDA’s recently confirmed commissioner Robert Califf, MD, may affect the dietary supplement industry.
    続きを読む 一部表示

あらすじ・解説

In this episode, the Nutritional Outlook editors interview Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP’s FDA and Healthcare practices. Previously, Durkin worked as the acting director and deputy director of the Office of Dietary Supplement Programs, in the FDA’s Center for Food Safety and Applied Nutrition. Given Durkin’s experience at FDA, he is well-qualified to provide some insights into how the leadership of FDA’s recently confirmed commissioner Robert Califf, MD, may affect the dietary supplement industry.

Episode 9: What does new FDA leadership mean for the dietary supplement industry?に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。